Latest ATNF reports update at 2023-11-09: 2023-Q3 ∙ 2022-Q4 ∙ 2022-Q3

180 Life Sciences Corp. ATNF

$ 2.04 2.51%

180 Life Sciences Corp. Balance Sheet 2011-2024 | ATNF

Annual Balance Sheet 180 Life Sciences Corp.

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	5.66 M	19.7 M	21.4 M	3.13 M	546 K	208 K	-	-	-	-	-	-
Total Liabilities	8.31 M	23.4 M	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-107 M	-68.7 M	-	-	-	-	-	-	-	-	-	-
Total Assets	19.7 M	62.7 M	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	2.11 M	547 K	271 K	428 K	67.2 K	-	-	-	-	-
Book Value	11.3 M	39.3 M	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	11.3 M	39.3 M	30.3 M	38.6 M	5 M	5 M	21.9 K	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet 180 Life Sciences Corp.

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	5.11 M	6.95 M	7.78 M	8.31 M	8.26 M	10.6 M	18.8 M	23.4 M	27.9 M	53.5 M	37.4 M	25.2 M	25.2 M	25.2 M	25.2 M	13.3 M	7.15 M	7.15 M	7.15 M	4.57 M	4.57 M	4.57 M	4.57 M	4.23 M	4.23 M	4.23 M	4.23 M	218 K	218 K	218 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-126 M	-116 M	-112 M	-107 M	-85.7 M	-64.2 M	-67.1 M	-68.7 M	-69.7 M	-88 M	-64.6 M	-48.4 M	-48.4 M	-48.4 M	-48.4 M	-37.5 M	1.07 M	1.07 M	1.07 M	1.16 M	1.16 M	1.16 M	1.16 M	121 K	121 K	121 K	121 K	-3.1 K	-3.1 K	-3.1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	4.96 M	13.7 M	14.9 M	19.7 M	34.3 M	53.4 M	59.7 M	62.7 M	65.1 M	56.3 M	60.1 M	55.5 M	55.5 M	55.5 M	55.5 M	51.9 M	12.5 M	12.5 M	12.5 M	118 M	118 M	118 M	118 M	117 M	117 M	117 M	117 M	240 K	240 K	240 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	3.59 M	1.63 M	5.67 M	8.22 M	11.7 M	1.84 M	6.05 M	2.11 M	32.7 K	2.11 M	2.11 M	83.4 K	547 K	547 K	547 K	567 K	271 K	271 K	271 K	428 K	428 K	428 K	428 K	67.2 K	67.2 K	67.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-149 K	6.72 M	7.14 M	11.3 M	26.1 M	42.8 M	40.9 M	39.3 M	37.1 M	2.72 M	22.7 M	30.3 M	30.3 M	30.3 M	30.3 M	38.6 M	5.35 M	5.35 M	5.35 M	114 M	114 M	114 M	114 M	113 M	113 M	113 M	113 M	21.9 K	21.9 K	21.9 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-149 K	6.72 M	7.14 M	11.3 M	26.1 M	42.8 M	40.9 M	39.3 M	37.1 M	2.72 M	22.7 M	30.3 M	30.3 M	30.3 M	30.3 M	38.6 M	5 M	5 M	5 M	-7.68 M	5 M	5 M	5 M	5 M	5 M	5 M	5 M	21.9 K	21.9 K	21.9 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency